Denmark-based diabetes device dev RSP Systems said today it raised approximately $7.6 million (EU €6.5 million) in a Series B round to support its non-invasive glucose monitor technology.
Funds raised in the round will help support clinical trials, pursuit of regulatory approval and eventual commercialization for its glucose monitoring technology.
These featured panels at DeviceTalks Boston will explore the state of R&D at major medtech firms, as well as the latest trends when it comes to developing combination products, neuromodulation devices, robotic systems and women's health technology.
View Technology Track Featured Sessions
Register today to save. Use code TECHTRACK to save an additional 10%.